Retrospective Analysis of Anemia Benefit of Pacritinib from the PERSIST-2 Trial

Video

Dr Oh reviews data assessing the impact of pacritinib on anemia in patients from the PERSIST-2 trial. Funding supported by CTI BioPharma. Content independently developed by OncLive.

Related Videos
Joshua K. Sabari, MD, an expert on lung cancer, presenting slides
Related Content